iiinova — where your digital self keeps evolving

Medicines for Malaria Venture (MMV) @mmv.org · 02/10/2026

What keeps progress against #malaria moving? In Liverpool, @malarianomoreuk.bsky.social ambassador Gab Astorga put that question to malaria scientists & global health experts. See what they had to say

010

Medicines for Malaria Venture (MMV) @mmv.org · 30/09/2026

PNG shoulders a disproportionate share of the Indo-Pacific's #malaria burden. Closing the gap means understanding why progress is harder in some settings vs others. In PNG, MMV met with partners & communities to explore the strategies and tools needed to accelerate elimination.

000

Medicines for Malaria Venture (MMV) @mmv.org · 24/09/2026

The Malaria Science Index shows how investment in #malaria R&D strengthens global health security and delivers #innovation beyond malaria. It also shows how UK science benefits from international collaboration. Sustained investment is key to elimination: bit.ly/47iA8HC

000

Medicines for Malaria Venture (MMV) @mmv.org · 24/09/2026

One dose to cure #malaria. That's the ambition behind WANECAM3, an Africa-Europe consortium developing new tools to change how we fight the disease. Prof. Abdoulaye Djimdé & his team in Mali are providing the scientific leadership to help make it happen: bit.ly/4cS0Dag

000

Medicines for Malaria Venture (MMV) @mmv.org · 22/09/2026

What will it take to end #malaria? New tools that can simplify care. Single-dose cures and long-acting prevention could become elimination accelerators, taking us closer to the finish line. Sustained investment can help get them there.

000

Medicines for Malaria Venture (MMV) @mmv.org · 17/09/2026

#ClimateChange is no longer simply a future threat, but a reality we need to manage and adapt to. For #malaria, building resilience is critical. This means developing simpler medicines that are easier to deliver and use, while strengthening health systems and supply chains.

020

Medicines for Malaria Venture (MMV) @mmv.org · 16/09/2026

#Malaria treatment and prevention needs vary by patient, context and setting. A new review explores how #innovation must respond, from simplifying treatment and providing longer-lasting protection to staying ahead of drug resistance. Read more: bit.ly/46m7KUO

000

Medicines for Malaria Venture (MMV) @mmv.org · 14/09/2026

Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW

022

Medicines for Malaria Venture (MMV) @mmv.org · 11/09/2026

Women should be protected through research, not from it. Healthcare decisions need evidence, but pregnant & breastfeeding women have historically been excluded from clinical research, leaving critical data gaps. Read our recommendations for ICH E21: bit.ly/3SKgP6C

011

Medicines for Malaria Venture (MMV) @mmv.org · 08/09/2026

#Malaria prevalence in Nigeria among children aged 6–59 months has declined by nearly 64% over the past 15 years. Sustained investment in prevention tools like SMC, treatment, surveillance and public awareness has helped drive this progress. Learn more: bit.ly/4qAN44B

020

Medicines for Malaria Venture (MMV) @mmv.org · 04/09/2026

MMV expresses profound sadness at the news of Vasee Moorthy’s untimely passing – we have lost an exceptional champion of global health. We will miss him sorely and send our deepest condolences to his myriad friends and his beloved family.

000

Medicines for Malaria Venture (MMV) @mmv.org · 02/09/2026

MMV has launched a request for information to identify organizations based in or operating in malaria-endemic countries for a new request for information on #malaria market intelligence and evidence generation. Deadline: 14 October Learn more: bit.ly/4cbgujY

011

Medicines for Malaria Venture (MMV) @mmv.org · 29/08/2026

From discovery to delivery, collaboration underpins progress against #malaria. This summer in Tokyo, MMV, the GHIT Fund and @gatesfoundation.bsky.social brought together partners from Japan and around the world to strengthen connections and discuss the future of malaria R&D: bit.ly/3UcIUnz

000

Medicines for Malaria Venture (MMV) @mmv.org · 28/08/2026

Encouraging Phase 2 results are supporting further development of a potential new #malaria treatment and prevention combination, which makes use of a promising new compound co-discovered by @ddu-dundee.bsky.social and MMV. Learn more: bit.ly/4gpdanQ

010

Medicines for Malaria Venture (MMV) @mmv.org · 20/08/2026

Global health challenges require global collaboration. This #WorldMosquitoDay, as MMV's flag flies over Geneva, we're celebrating the city's role as a meeting point where partnerships connect expertise and #innovation with communities around the world. 🦟🌍

000

Medicines for Malaria Venture (MMV) @mmv.org · 20/08/2026

Building bridges is what we do. For 25+ years, MMV has connected people, expertise and resources around the world. Different bridges, one destination: a #malaria-free future. A fitting spot for our #WorldMosquitoDay group shot!

020

Medicines for Malaria Venture (MMV) @mmv.org · 17/08/2026

#Malaria exploits disruption. A new @malariaconsortium.bsky.social study explores the challenges of delivering SMC in conflict- and flood-affected South Sudan, with lessons other complex settings can benefit from. Read more: bit.ly/4gsQByo

010

Medicines for Malaria Venture (MMV) @mmv.org · 14/08/2026

📢 Call for applications! @afro.who.int & TDR are supporting locally driven implementation research to strengthen health research capacity and generate evidence for countries. Applications: EN, FR & PT Deadline: 15 Sept 2026 Apply: bit.ly/4q9lV8A

020

Medicines for Malaria Venture (MMV) @mmv.org · 13/08/2026

What can a century of #malaria surveillance reveal about the impact of #ClimateChange in Africa? A study in @nature.com finds its impact on childhood malaria varies considerably across the continent, with new risks emerging in East & Southern Africa. More: bit.ly/4g0Yhyh

000

Medicines for Malaria Venture (MMV) @mmv.org · 12/08/2026

#Malaria prevention saves lives. It can also be an investment in children's education & future productivity. A new study suggests expanding SMC to school-aged children could deliver billions in health & economic benefits. More: bit.ly/4fDHBVu

010

Medicines for Malaria Venture (MMV) @mmv.org · 07/08/2026

Pregnant & breastfeeding women must be protected through clinical research, not from it. MMV & partners are calling for actionable guidance to support their inclusion in clinical research and generate robust evidence: bit.ly/4wLXBwa #WorldBreastfeedingWeek

000

Medicines for Malaria Venture (MMV) @mmv.org · 05/08/2026

Relapsing #malaria can cause repeated episodes of illness from a single mosquito bite. A new study from Papua New Guinea & Indonesia is helping build the evidence needed to introduce improved approaches into routine care. More: bit.ly/4fwLLOV

000

Medicines for Malaria Venture (MMV) @mmv.org · 30/07/2026

Congrats to MMV's André-Marie Tchouatieu, who was recognized for his visionary leadership in the fight against #malaria at Benin's La Nuit du Paludisme. The Exceptional Commitment Award celebrates his success in mobilizing minds, inspiring generations and saving countless lives.

010

Medicines for Malaria Venture (MMV) @mmv.org · 23/07/2026

MMV met with leaders from the Japan Institute for Health Security (JIHS) to discuss Japan's approach to #malaria and health security, showcase MMV's pipeline of innovative malaria medicines and explore opportunities for future collaboration.

000

Medicines for Malaria Venture (MMV) @mmv.org · 22/07/2026

Long-acting injectables could provide protection from malaria for up to 6 months with a single administration. Cristina Donini explains how it works. Reaching zero #malaria requires continued #innovation & sustained commitment to get breakthroughs to those who need them most.

000

Medicines for Malaria Venture (MMV) @mmv.org · 21/07/2026

From discovery to delivery, collaboration across the global malaria community underpins innovation and progress. Here are three ways Japan contributes to the fight against one of the world's deadliest diseases.

001

Medicines for Malaria Venture (MMV) @mmv.org · 14/07/2026

A single-dose cure for #malaria: one patient, one visit, one treatment, done. MMV’s Cristina Donini explains how it works. Reaching zero malaria requires continued #innovation and the sustained commitment to get the latest breakthroughs to the people who need them most.

000

Medicines for Malaria Venture (MMV) @mmv.org · 13/07/2026

Last week, representatives from the MMV/DNDi joint regulatory sciences platform and medical affairs met with the Ghana FDA at the Ghanaian Mission in Geneva to discuss how we can reinforce our shared commitment to closer regulatory collaboration.

000

Medicines for Malaria Venture (MMV) @mmv.org · 10/07/2026

MMV convened experts in clinical trials, immunology, modelling  & machine learning to define the data needed to build AI-powered models of the immune response to #malaria. Learn more about 3 of our latest AI drug discovery and development partnerships: bit.ly/4yalrCN

000

Medicines for Malaria Venture (MMV) @mmv.org · 07/07/2026

From single-dose cures to long-acting injectables, next-gen #malaria tools could transform how the disease is prevented & treated. Today, MMV's Cristina Donini features in the Daily Express, photographed by Rankin for @malarianomoreuk.bsky.social's #FacesOfInnovation campaign: bit.ly/4woWi5v

001

Medicines for Malaria Venture (MMV) @mmv.org · 29/06/2026

EU ability to prevent, detect and respond to infectious diseases relies on global collaboration and thriving #innovation. In this joint paper with PDP partners, we highlight @globalhealthedctp3.bsky.social's role in Europe–Africa research, clinical development and access: bit.ly/4xKn21U

141

Medicines for Malaria Venture (MMV) @mmv.org · 16/06/2026

A new version of #MMVSola is now live 🔹 Dose prediction tools for LAIs 🔹 Enhanced interactive plots & tables 🔹 Improved models to better estimate drug properties 🔹 Built-in documentation & user guides Try it for free here: mmvsola.org

001

Medicines for Malaria Venture (MMV) @mmv.org · 05/06/2026

MMV’s Project of the Year 2025 is a powerful example of how we can go farther and faster by working together. This week, we convened the partners behind Coartem® Baby, the first #malaria treatment specifically designed for newborns and young infants: bit.ly/4en79Xw

020

Medicines for Malaria Venture (MMV) @mmv.org · 03/06/2026

Another milestone in the treatment of vivax #malaria. Thailand is the second country to approve paediatric tafenoquine, a single-dose treatment designed to help prevent relapse. Co-developed by MMV and GSK, pTQ can help children recover without the threat of repeated relapse.

111

Medicines for Malaria Venture (MMV) @mmv.org · 02/06/2026

MMV’s 9th African call for proposals is now open! We’re looking for projects that could help accelerate #malaria drug discovery, from assay development and AI-supported discovery to innovative biology and novel antimalarials. Apply by 29 August: bit.ly/3Rt1h6j

000

Medicines for Malaria Venture (MMV) @mmv.org · 28/05/2026

As #malaria becomes more complex, we need simpler tools. #Innovations like single-dose cures & long-acting injectables can accelerate elimination in complex settings. Because the best innovations are the ones people actually use. That’s what makes them elimination accelerators.

011

Medicines for Malaria Venture (MMV) @mmv.org · 27/05/2026

What does it take to move new health technologies from pilot projects into routine care? Last month in Thailand, MMV colleagues joined NMPs from across the Asia-Pacific to observe the implementation of tools for relapsing #malaria in real-world settings & exchange insights.

010

Medicines for Malaria Venture (MMV) @mmv.org · 26/05/2026

MMV delivered statements at #WHA79 this week, ensuring that #malaria is high on the global health agenda and strengthening the connection between elimination and broader health security. Read the statements: bit.ly/49YdLZK

000

Medicines for Malaria Venture (MMV) @mmv.org · 20/05/2026

What will it take to get malaria elimination back on track in Africa? At #WHA79, MMV & partners convened leaders across research, policy & global health to discuss how to move new #malaria tools from development into widespread use.

110

Medicines for Malaria Venture (MMV) @mmv.org · 18/05/2026

New #malaria tools are expanding what’s possible in prevention, treatment & elimination. But #innovation alone is not enough. How can countries accelerate access & delivery at scale & translate innovation into lasting impact? Join us tomorrow at #WHA79: bit.ly/4uFHONN

000

Medicines for Malaria Venture (MMV) @mmv.org · 16/05/2026

This week, MMV and @dndi.org drug discovery teams came together to exchange ideas, common challenges and lessons learned across our research. From prioritizing promising compounds to advancing research in endemic countries, shared learning helps strengthen global health #innovation.

072

Medicines for Malaria Venture (MMV) @mmv.org · 15/05/2026

British science is behind 1 in 5 tools in the antimalarial R&D pipeline. Sustaining investment in UK malaria research could accelerate progress towards #malaria elimination while generating ripple effects across global health and economic development: bit.ly/49vc8T5

021

Medicines for Malaria Venture (MMV) @mmv.org · 12/05/2026

Funding cuts, resistance, climate change and conflict are creating a perfect storm that threatens progress against #malaria. A new perspective paper co-authored by MMV’s George Jagoe explores what malaria research must prioritize next: bit.ly/4tjf9xb

010

Medicines for Malaria Venture (MMV) @mmv.org · 07/05/2026

Baby Wonder was just 12 weeks old when he developed #malaria. He was brought to a hospital and treated with Coartem® Baby and is now back home with his family. Now @who.int prequalified, this treatment can reach more newborns & young infants, closing a critical gap in malaria care.

111

Medicines for Malaria Venture (MMV) @mmv.org · 06/05/2026

At #RNPM26 in Brazil, MMV marked #WorldMalariaDay by discussing advances in tackling relapsing vivax #malaria. Brazil’s rollout of new tools like single-dose tafenoquine is helping redefine what’s possible for elimination.

011

Medicines for Malaria Venture (MMV) @mmv.org · 06/05/2026

Funding opportunity for women researchers in sub-Saharan Africa. 2026 L’Oréal-UNESCO For Women in Science Programme: • PhD & postdoc (SSA) • 30 PhD + 8 postdoc grants • €10k / €15k + leadership training Deadline: 15 May 2026 Apply: bit.ly/4cXDgv6

011

Medicines for Malaria Venture (MMV) @mmv.org · 30/04/2026

How are partnerships strengthening R&D capacity in Africa & what does this mean for #malaria? At a #WHSNairobi2026 side event, MMV & partners highlighted initiatives like RAFIKI, which is strengthening R&D in endemic countries while fostering new Africa/Europe collaborations. #WorldMalariaDay

021

Medicines for Malaria Venture (MMV) @mmv.org · 28/04/2026

United in the fight against #malaria and staying one step ahead of antimalarial drug resistance. Building on the momentum of #WorldMalariaDay, yesterday MMV and the RBM Partnership to End Malaria convened partners in Geneva to align and strengthen our collective response to drug resistance.

141

Medicines for Malaria Venture (MMV) @mmv.org · 27/04/2026

Progress against #malaria is accelerating, but the last mile is the hardest. In Bangkok, APMEN is convening 19 countries to share research and tools to advance elimination across the Asia Pacific. #WorldMalariaDay

020

Medicines for Malaria Venture (MMV) @mmv.org · 27/04/2026

#PressRelease Brazil is the first country to roll out paediatric tafenoquine, closing a critical gap in treating relapsing #malaria in children. Co-developed by MMV and GSK, this child-friendly formulation makes treatment easier to complete and helps prevent relapse.

132